Evidence map›Paper›PMID 38969849›Full record

ArticleAnnals of surgical oncology2024

Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.

Élise Di Lena, Ericka Iny, Stephanie M Wong, Miranda Bassel, Arusa Shah, Mark Basik, Jean-François Boileau, Karyne Martel, Sarkis Meterissian, Ipshita Prakash

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Extent of resection in breast conserving surgery after neoadjuvant chemotherapy: a literature review.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Élise Di LenaDepartment of Surgery, McGill University, Montreal, Canada.
Ericka InyMcGill University Medical School, Montreal, Canada.
Stephanie M WongDepartment of Surgery, McGill University, Montreal, Canada.
Miranda BasselDepartment of Surgery, McGill University, Montreal, Canada.
Arusa ShahFaculté de médecine, Université de Montréal, Montreal, Canada.
Mark BasikDepartment of Surgery, McGill University, Montreal, Canada.
Jean-François BoileauDepartment of Surgery, McGill University, Montreal, Canada.
Karyne MartelDepartment of Surgery, McGill University, Montreal, Canada.
Sarkis MeterissianDepartment of Oncology, McGill University, Montreal, Canada.
Ipshita PrakashDepartment of Surgery, McGill University, Montreal, Canada. ipshita.prakash@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQuestions have been raised as to an increased risk of local recurrence with breast-conserving surgery (BCS) post NAC highlighting the uncertainty around optimal margin width in this patient population. We examined the association between margin status and local recurrence-free survival (LRFS) in patients who underwent BCS following NAC.

methodsWe performed a retrospective cohort study of adult female patients with stage I-III breast cancer who underwent NAC followed by BCS between 2012 and 2021 at two cancer centers. Margins were categorized as "close" if they were < 1 mm.

resultsThe full cohort included 544 patients with a median age of 53 years (interquartile range [IQR] 44-64). Pathologic complete response (pCR) was achieved in 41.2% of the overall cohort (n = 224). Of the 320 with residual disease, 29.4% (n = 94) had at least one close margin, and 10.9% (n = 35) had ≥2 close margins. Median follow-up was 55 months (IQR 32-83); 4.8% had an ipsilateral breast recurrence (n = 26). Patients with pCR had a higher 5-year LRFS than those with residual disease (98.0% vs. 91.6%, p = 0.02). There was no difference in 5-year LRFS between the margin categories (clear vs. 1 close margin vs. ≥2 close margins) in those with residual disease (92.2% vs. 88.9% vs. 92.9%) (p = 0.78).

conclusionsIn patients undergoing BCS post-NAC, those who achieved pCR had a significantly higher LRFS compared with those with residual disease at the time of surgery, but LRFS was not associated with margin width nor the number of close margins.

Indexed as

Breast NeoplasmsMargins of ExcisionMastectomy, SegmentalNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm, ResidualAdultAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Ductal, BreastChemotherapy, AdjuvantFemaleFollow-Up StudiesHumansMiddle AgedNeoplasm StagingPrognosisBreast conserving surgeryMarginsNeoadjuvant chemotherapyRecurrence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.